Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€4.10
27.11.22
-
27.11.23
-75.96%
08.12.22

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€95.50
26.11.22
-
26.11.23
-45.74%
27.11.23

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
24.11.22
-
24.11.23
-5.00%
26.11.22

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€5.00
22.11.22
-
22.11.23
8.00%
18.05.23

buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€4.37
22.11.22
-
22.11.23
-16.39%
26.11.22

buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.72
22.11.22
-
22.11.23
-66.14%
23.11.23

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.18
21.11.22
-
21.11.23
-1.12%
26.11.22

Risky Investment
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.58
21.11.22
-
21.11.23
-85.09%
22.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€15.40
21.11.22
€18.00
21.11.23
4.32%
06.12.22

CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.63
19.11.22
€2.50
19.11.23
-46.91%
11.03.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
buy
Eiger Biopharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.87
19.11.22
-
19.11.23
5.10%
07.12.22

Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.99
18.11.22
-
18.11.23
15.65%
26.12.22

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.85
17.11.22
-
17.11.23
-17.52%
27.11.22

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.58
17.11.22
-
17.11.23
-14.78%
26.12.22

Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.93
17.11.22
€0.000
17.11.23
53.02%
23.01.23

buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.49
17.11.22
-
17.11.23
-5.85%
04.04.23

PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€8.13
16.11.22
€2.00
16.11.23
5.88%
23.01.23

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€4.62
16.11.22
€1.00
16.11.23
26.73%
23.01.23

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.88
16.11.22
-
16.11.23
-90.21%
17.11.23

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€14.20
16.11.22
-
16.11.23
93.80%
17.07.23

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€5.00
16.11.22
€1.00
16.11.23
17.18%
23.01.23

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€2.26
15.11.22
€3.50
15.11.23
-80.00%
16.11.23

buy
Lumos Pharma Inc.

Start price
Target price
Perf. (%)
€4.82
15.11.22
-
15.11.23
-33.61%
11.12.22